4.5 Article

KCa3.1 regulates cell cycle progression by modulating Ca2+signaling in murine preosteoblasts

期刊

JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 153, 期 3, 页码 142-152

出版社

JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2023.09.001

关键词

Mouse preosteoblast; KCa3.1; Cell cycle; Cell proliferation

向作者/读者索取更多资源

This study demonstrated that KCa3.1, a Ca2+-activated K+ channel, is upregulated in preosteoblastic cells, leading to hyperpolarization and enhanced intracellular Ca2+ signaling. Inhibition of KCa3.1 attenuated cell cycle progression and inhibited osteoblast differentiation. These findings reveal the important role of KCa3.1 in regulating osteoblast maturation during bone formation.
Osteoblasts synthesize and deposit essential components of the extracellular bone matrix and collagen scaffolds, leading to mineralized bone formation. Therefore, the proliferation of preosteoblasts (precursors of mature osteoblasts) helps in regulating skeletal homeostasis. This study demonstrated that the functional expression of KCa3.1, an intermediate-conductance Ca2+-activated K+ channel, is markedly upregulated in murine preosteoblastic MC3T3-E1 cells in the G0/G1 phase. The enhancement of KCa3.1 is involved in the establishment of more negative membrane potentials in MC3T3-E1 cells. This hyperpolarization can promote intracellular Ca2+ signaling because store-operated Ca2+ channels are activated. Treatment with TRAM34, a specific KCa3.1 inhibitor, attenuated the cell cycle progression from the G0/ G1 phase to the S/G2/M phases. In MC3T3-E1 cells, KCa3.1 significantly promoted the transition from the G1 phase to the S phase. KCa3.1 inhibition also caused G0 phase cell accumulation. Furthermore, TRAM -34 decreased the expression of alkaline phosphatase, bone sialoprotein, and osteocalcin, osteoblast differentiation markers in MC3T3-E1 cells, and inhibited the endochondral ossification of murine metatarsals. These results reveal novel ways by which KCa3.1 activity can strongly modulate osteoblast maturation during bone formation.(c) 2023 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据